Capmatinib shows superior efficacy for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy [RNA-seq]
RNA-seq (gene expression) · mouse · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 36 samples
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMolecular cancer · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE247864_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1040829 and SRA study SRP472165. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Load samples and it will be fetched from NCBI.
+ 36 more — browse all 36 samples with per-sample file links →
- GSE283503 Ptp1b inhibition improves the macrophage anti-tumor immune response and the efficacy of chemo- and radiotherapy. 16 samples shares radiotherapy, efficacy
- GSE280080 Radiotherapy synergizes with AAV-based immunotherapy to program local and systemic antitumor immunity 15 samples shares radiotherapy, synergizes
- GSE255971 The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models [RNA-seqII] 12 samples shares high-grade, pediatric
- GSE255242 41BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy in murine breast tumor 12 samples shares radiotherapy, synergizes
- GSE280078 Radiotherapy synergizes with AAV-based immunotherapy to program local and systemic antitumor immunity [scRNA-Seq] 8 samples shares radiotherapy, synergizes
- GSE279226 Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment. 8 samples shares high-grade, efficacy
- GSE280079 Radiotherapy synergizes with AAV-based immunotherapy to program local and systemic antitumor immunity [RNA-Seq] 7 samples shares radiotherapy, synergizes
- GSE279819 Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment. [cell line] 6 samples shares high-grade, efficacy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.